About
T cell immunotherapy for Vaccines
Areas of Focus
Categories
VaccineStem Cell & Cellular TherapyVirginia, DC, DE & Maryland
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
3,797
By Phase
EARLY_PHASE1: 2PHASE1/PHASE2: 4PHASE2: 4PHASE1: 1
By Status
COMPLETED: 5TERMINATED: 4RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06310291Lead Sponsor
VTP-1000 in Adults With Celiac Disease
EARLY_PHASE1Recruiting
45 participants
Started: Aug 1, 2024 · Completed: Jun 30, 2026
NCT05617040Lead Sponsor
Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer
PHASE1/PHASE2Terminated
22 participants
Started: Jan 30, 2023 · Completed: Feb 5, 2025
NCT05343481Lead Sponsor
Efficacy of VTP-300 in Chronic Hepatitis B Infection
PHASE2Active, not recruiting
120 participants
Started: Sep 21, 2022 · Completed: Oct 31, 2026
NCT04607850Lead Sponsor
Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions
PHASE1/PHASE2Completed
108 participants
Started: Mar 16, 2021 · Completed: Jan 16, 2024
NCT04778904Lead Sponsor
First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV
PHASE1/PHASE2Completed
55 participants
Started: Dec 22, 2020 · Completed: Feb 24, 2023
Locations (1)
Headquarters
Germantown, MD, United States
Map
Loading map...